We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
PEA wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
6 of 6 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
4 of 4 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both PEA and White Willow Bark have evidence — compare verdict strength side-by-side.
600-1200mg
With meals, Split into 2-3 doses
Micronized or ultra-micronized PEA
120-240mg salicin daily (from standardized extract)
With meals, Divided doses
Standardized extract (15% salicin)
2-8 weeks
4-8 weeks
Ongoing
1-2 weeks
1-4 weeks
Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta analysis · n=742
These two obtained scores corresponded to a 35.1% pain intensity reduction within the first month, followed by a further 35.4% during the second month.
Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
Nutrients (2023) · Meta analysis · n=774
PEA was found to reduce pain scores relative to comparators in a pooled estimate, with a standard mean difference of 1.68 (95% CI 1.05 to 2.31, p = 0.00001).
Navigating agitation in neurodevelopmental disorders: A comparative study of pharmacotherapies via network meta-analysis in children and adults with autism spectrum disorder or intellectual disabilities
Journal of psychopharmacology (Oxford, England) (2025) · Meta analysis · n=2503
Importantly, these treatments were generally well-tolerated, with no significant increase in all-cause dropouts compared to placebo, highlighting their suitability for clinical use in managing agitation in individuals with ASD or ID.
Efficacy and Safety of White Willow Bark (Salix alba) Extracts
Phytotherapy research : PTR (2015) · Systematic review
In recent years, various in vitro and animal studies have demonstrated that the anti-inflammatory activity of willow bark extract is associated with down regulation of the inflammatory mediators tumor necrosis factor-α and nuclear factor-kappa B.
A systematic review on the effectiveness of willow bark for musculoskeletal pain
Phytotherapy research : PTR (2009) · Systematic review
All studies investigated ethanolic extracts with daily doses up to 240 mg salicin over periods of up to six weeks.
Cochrane review: Herbal therapy for low back pain
Cochrane Database of Systematic Reviews (2006) · Systematic review · n=500
Moderate evidence of efficacy
Based on multiple meta-analyses showing ~35% pain reduction. Studies primarily used micronized formulations which may have better bioavailability than standard forms. Most benefits observed within 4-6 weeks of treatment.
Based on Cochrane review showing dose-response relationship with 240mg more effective than 120mg. Studies limited to 6 weeks duration. Requires salicin-standardized extract.
AI-estimated from published studies. Interpret as directional guidance.
PEA has a higher evidence score (7.5/10 vs 6/10) and wins in 3 of 3 categories.
For joint health & mobility, White Willow Bark has a higher relevance score (88 vs 85).
No known interactions between PEA and White Willow Bark have been documented in our database. However, always consult a healthcare provider before combining supplements.